RKDA ARCADIA BIOSCIENCES INC Business Restructuring 8-K Filing 2023 - Management Changes On July 20, 2023, Arcadia Biosciences, Inc. announced that they are carrying out a strategic review to explore financial and strategic alternatives aimed at increasing long-term shareholder value. This followed the presentation of the company's cash equivalents as of June 30, 2023, and the expected revenue range for the second quarter of 2023.Get access to all SEC 8-K filings of the ARCADIA BIOSCIENCES INC